In our series, The ECS Community Adapts and Advances, Alex Peroff spoke to us from his home office. Whereas travel used to be the largest part of his job, now he focuses on developing content and meaningful communication. Alex joined Pine Research Instrumentation, Inc. as an Electroanalytical Scientist in 2016 after completing a PhD at Northwestern University.
The pandemic sent shockwaves through the academic community. Some institutions are weathering the storm better than others. At Lewis University (LU), Professor Jason Keleher and his students, Carolyn Graverson, Abigail “Abby” Linhart, and Katie Wortman-Otto, are optimistic. In our series, The ECS Community Adapts and Advances, they share their COVID-19 experiences and hopes for the future.
As the global response to the SARS-COV-2 virus that causes COVID-19 approaches 200 days, Baylor Scott & White Research Institute, the research and development arm of Baylor Scott & White Health, is accelerating its pace of bringing clinical trials online.
Baylor Scott & White Research Institute continues to mobilize staff and resources, including components needed to integrate critical patient-safety measures at every participating site within the Baylor Scott & White system for industry sponsored drug trials, investigator-initiated drug trials and research studies, and observational and data studies designed to help increase knowledge around case trends, viral epidemiology, and care best practices.
• The SAMBA II diagnostic device cuts COVID-19 test result times from over 24 hours to just two hours.
• First “real-world” study of SAMBA devices on hospital wards finds patient time on COVID ‘holding wards’ was almost halved.
• Researchers say faster tests helped free up beds and expedite access to life-saving treatments such as organ transplants – and might make all the difference later this year.
A new international project aims to enroll 500 COVID-19 patients to search for genetic mutations that make some people more vulnerable to severe infection.
For many years, Pinar Keskinocak has studied how pandemics spread through the nation, how they overburden health care systems, and how they diminish the supply of medications, thus worsening the pandemic. All this also spins off additional medical crises. She…
As COVID-19, the disease caused by the new coronavirus, spreads across the globe, scientists are stepping up to the plate to address the numerous unanswered questions emerging in its wake.
A Virginia Tech historian who studies World War II says America once again requires that kind of bold effort if we’re to best mitigate the effects the novel coronavirus’ spread. “The lesson of that costly war is that government officials…
A Virginia Tech expert in gerontology — the study of old age and the process of aging — encourages families to stay connected with their older loved ones while practicing social distancing, even as new challenges increase the complexity of…
One of the biggest unknowns about coronavirus is how changing seasons will affect its spread. Physicists from the University of Utah have received a NSF grant to create individual coronavirus particles without a genome. They’ll test how the structure of the coronavirus withstands changes in humidity and temperature.
As the COVID-19 pandemic spreads, people have been asked to stay out of public spaces and reduce interpersonal contact to limit the transmission of the virus. This process has the unfortunate name of “social distancing,“ which has connotations of removing oneself socially and emotionally as well as physically from the public sphere.
Health care network deploys diagnostic to faster respond to outbreaks as they happen
Virginia Tech experts on a variety of subjects are available for media interviews related to SARS-CoV-2 (commonly referred to as the novel coronavirus.) Media experts: History of epidemics— Expert who studies history of epidemics: ‘Panic may be the worst possible response’…
An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new study led by researchers at Johns Hopkins Bloomberg School of Public Health.